Education
About Us
Working with TipRanks
Follow Us
Cosmo Feilding-Mellen Insider Profile
4 Followers
Cosmo Feilding-Mellen, Director at ATAI Life Sciences, holds 7.66M shares in ATAI Life Sciences (Ticker: ATAI). Most recently, Cosmo Feilding-Mellen Sold 39,594 shares of ATAI Life Sciences on Jan 06, 2026 for an estimated value of $154.02K.
Cosmo Feilding-Mellen has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Cosmo Feilding-Mellen's holdings
Insider Roles
Director
Roles that Cosmo Feilding-Mellen holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Cosmo Feilding-Mellen
Cosmo Feilding-Mellen's Trading History
List of latest transactions for each holding click on a transaction to see Cosmo Feilding-Mellen's performance on stock
You May Also Like
Cosmo Feilding-Mellen insider profile FAQ
What is the percentage of profitable transactions made by Cosmo Feilding-Mellen?
The percentage of profitable transactions made by Cosmo Feilding-Mellen is ―.
What is the average return per transaction made by Cosmo Feilding-Mellen?
The average return per transaction made by Cosmo Feilding-Mellen is ―.
What stocks does Cosmo Feilding-Mellen hold?
Cosmo Feilding-Mellen holds: ATAI stocks.
What was Cosmo Feilding-Mellen’s latest transaction?
Cosmo Feilding-Mellen latest transaction was an Informative Sell of $154.02K.
What was Cosmo Feilding-Mellen's most profitable transaction?
Cosmo Feilding-Mellen’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Cosmo Feilding-Mellen's role in ATAI Life Sciences?
Cosmo Feilding-Mellen's role in ATAI Life Sciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.